Alaunos Therapeutics Inc. (TCRT) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alaunos Therapeutics Inc.

    NASDAQ: TCRT · Real-Time Price · USD
    2.13
    0.03 (1.43%)
    At close: Aug 29, 2025, 3:59 PM
    2.09
    -1.88%
    After-hours: Aug 29, 2025, 06:44 PM EDT

    Alaunos Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -4.68M -35.14M -37.73M -78.75M
    Depreciation & Amortization
    		 2K 2.31M 2.76M 2.6M
    Stock-Based Compensation
    		 435K 2.8M 3.53M 10.77M
    Other Working Capital
    		 n/a -5.48M -2.14M 2.52M
    Other Non-Cash Items
    		 -729K 6.14M 3.27M 383K
    Deferred Income Tax
    		 n/a n/a n/a 740K
    Change in Working Capital
    		 -729K -6.25M -1.06M 2.79M
    Operating Cash Flow
    		 -4.97M -30.14M -29.23M -61.47M
    Capital Expenditures
    		 n/a -197K -216K -3.32M
    Cash Acquisitions
    		 n/a n/a 23K n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a 1.54M 23K n/a
    Investing Cash Flow
    		 n/a 1.35M -193K -3.32M
    Debt Repayment
    		 n/a -18.11M -8.33M 25M
    Common Stock Repurchased
    		 n/a n/a -45K n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -125K 21K 776K
    Financial Cash Flow
    		 n/a -18.14M 6.37M 25.78M
    Net Cash Flow
    		 -4.97M -46.93M -23.06M -39.02M
    Free Cash Flow
    		 -4.97M -30.34M -29.45M -64.79M

    Add to Watchlist